A final clinical study protocol for DefenCath in Total Parenteral Nutrition (TPN) was submitted to FDA in Q4, and study enrollment is expected to begin in H1 2025. The Company also expects patient ...
Xeltis, a leading developer of transformative implants that enable the natural creation of living and long-lasting vessels, today announces the completion of enrolment in its EU Pivotal trial for ...
dicentra congratulates SterileCare on achieving a significant milestone in their innovative catheter lock solution clinical trial, with 20 patients enrolled as of December 30, 2024. The trial, which ...
The Georgetown Public Hospital Corporation (GPHC) in a release yesterday announced that its medical staff performed Guyana’s first neonatal peritoneal ...
Single- and double-purse-string suture catheter insertion methods for peritoneal dialysis are associated with comparable postinsertion complication and technical survival rates.